Cloopen Group Holding Limited Sponsored ADR RAAS
1.13
0.00
0.00%
as of 11 Jun
- Market cap
- $121.2M
- P/E
- 0.0×
Follow RAAS
| Older periods | Mar '21 | Jun '21 | Sep '21 | Dec '21 | |
|---|---|---|---|---|---|
|
+3 more TTM periods Free account |
— | (424.91%) | (426.60%) | 505.37% | |
| — | (167.77%) | (164.28%) | (291.16%) | ||
ROIC |
0.00% | 0.00% | (16.98%) | 0.00% | |
Return on Tangible Assets |
0.00% | (132.80%) | (118.09%) | (285.64%) | |
Average Days of Receivables |
0.00 | 149.46 | 133.19 | 77.12 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | (2.03) | |
Free Cash Flow |
— | — | — | (99.61) | |
Capital Expenditures |
— | — | — | (3.40) | |
Piotroski F-Score |
— | 0.00 | 0.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
0.00% | 0.00% | 0.00% | (13.01%) | |
Accounts Receivable Turnover |
— | 3.12 | 3.40 | 3.78 | |
Accounts Payable Turnover |
— | 3.73 | 3.91 | 3.48 | |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 97.79 | 112.56 | 112.38 | |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
— | 0.00 | (0.03) | 0.01 | |
Research and Development Expense of Revenue |
— | 22.68% | 25.42% | 39.51% | |
Selling, General and Administrative Expense of Revenue |
— | 61.67% | 60.00% | 91.08% | |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
— | — | 0.00 | 0.00 | |
Operating CF/Net income |
— | 0.00 | 0.00 | 0.11 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 1.89 | |
Capex/Depreciation |
— | — | — | (0.81) | |
Revenue per Share |
0.00 | 2.56 | 2.71 | 2.40 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | (1.96) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.07) | |
Capex to Sales |
— | 0.00 | 0.00 | 0.03 | |
Net Profit Margin |
— | (381.99%) | (326.60%) | (768.25%) |
Columns are period end dates